Financial Data and Key Metrics Changes - For Q3 2025, the company reported GAAP net income of $48 million, or $0.34 per diluted share, with distributable earnings of $42 million, or $0.30 per share [8] - Run rate distributable earnings were $32 million, or $0.23 per share, slightly below the dividend level due to the timing of capital redeployment [8][9] - The book value per share, excluding general CECL allowance and depreciation, was $12.73 at the end of the quarter [10] Business Line Data and Key Metrics Changes - The company committed to an additional $1 billion of new loans during the quarter, bringing year-to-date originations to $3 billion [4][10] - Residential loans represent the largest underlying property type in the portfolio at 31% [5] - The loan portfolio's carrying value totaled $8.3 billion, with a weighted average unleveraged yield of 7.7% [10][12] Market Data and Key Metrics Changes - The company is the most active alternative lender in Europe, benefiting from a fragmented lender universe and healthy fundamentals across property types [4] - Repayments during the quarter totaled $1.3 billion, bringing year-to-date repayments to $2.1 billion [5][10] - The weighted average risk rating of the portfolio remained unchanged at 3.0 [11] Company Strategy and Development Direction - The company is focused on capital rotation out of focus assets, which is expected to have a meaningful impact on earnings going forward [6][9] - The strategy includes diversifying the lender base and expanding sources of capital, with a new secured borrowing facility established in Europe [6][12] - The company aims to maintain leverage levels around four times when fully deployed and capital efficient [17][38] Management's Comments on Operating Environment and Future Outlook - Management noted improved operating performance in the broader real estate market, with capital markets fully open and a healthy pace of repayments expected to continue [22][23] - The company anticipates bringing The Brooke to market in late spring or early summer 2026, with hopes of closing a transaction in late Q3 or early Q4 [16][20] - Management expressed optimism regarding the office portfolio, noting increased leasing momentum in key markets like New York and London [44] Other Important Information - The company recognized a $17.4 million gain from a litigation settlement, contributing to an increase in book value per share [10] - Liquidity at the end of the quarter was strong at $312 million, with leverage down from 4.1 times to 3.8 times [12] Q&A Session Summary Question: Update on focused assets and timeline for monetizing The Brooke and 111 West 57th Street - Management expects to finish selling remaining units at 111 West 57th Street in early 2026 and plans to bring The Brooke to market in late spring or early summer 2026 [15][16] Question: Thoughts on leverage levels for the business - Management indicated a target leverage level in the mid-threes, with a focus on originating senior loans and maintaining capital efficiency [17] Question: Update on Liberty Center asset - Management is involved in the bankruptcy process of the parent company of the movie theater at Liberty Center and expects to assess timing for an exit in late Q1 or early Q2 of next year [20][21] Question: Elevated repayment levels in Q3 - Management attributed the increase in repayments to open capital markets and improved operating performance across asset classes, expecting a healthy pace of repayments to continue [22][23] Question: Update on office portfolio trends - Management noted positive leasing momentum in key markets and increased capital market activity for office deals [44]